News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
UK Study Warns Against Johnson & Johnson (JOBS), Eli Lilly and Company (JOBS), AstraZeneca PLC (JOBS) Anti-Psychotics for Dementia
November 12, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- More than 140,000 dementia patients in Britain are given anti-psychotic drugs needlessly and overprescribing of the medicines is linked to an extra 1,800 deaths in elderly people each year, a report said on Thursday.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Postmarket research
AstraZeneca Pharmaceuticals LP
Johnson & Johnson Family of Companies
Eli Lilly and Company
MORE ON THIS TOPIC
Obesity
Novo may have muscle advantage over Lilly in weight-loss race: preprint
April 17, 2026
·
2 min read
·
Tristan Manalac
Insights
Funding the future of European biotech
April 16, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Gene therapy
MeiraGTx, spying hope in a failed trial, buys back eye disease gene therapy from J&J
April 16, 2026
·
2 min read
·
Annalee Armstrong
diabetes
Lilly’s Foundayo posts ‘outstanding’ diabetes data, possibly easing FDA safety concerns
April 16, 2026
·
2 min read
·
Gabrielle Masson